Tue, Dec 23, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay Hedge Fund Index gains 0.85% in July (3.19% YTD) in difficult trading environment

Wednesday, August 15, 2012
Opalesque Industry Update – Hedge funds gained 0.85% in July 2012, according to the Barclay Hedge Fund Index compiled by BarclayHedge. The Index is up 3.19% year to date.

“Equity markets see-sawed in July, driven up and down by economic reports in the most recent news cycle,” says Sol Waksman, founder and president of BarclayHedge.

“Poor economic data drove markets down, and hopes of action by governments and central banks rallied the markets. It was a very difficult trading environment for many strategies.”

In July, 17 of Barclay’s 18 hedge fund indices had positive returns. The Barclay Equity Short Bias Index rebounded with a 3.16% gain, Global Macro added 1.56%, the Event Driven Index gained 1.54%, Distressed Securities were up 1.41%, and the Multi Strategy Index rose 1.12%.

“When the dust settled at month’s end, prices for equities, bonds and commodities were mostly higher,” says Waksman.

The only losing hedge fund strategy in July was the Pacific Rim Equities Index, which slid 0.04%.

Year to date, the Healthcare & Biotechnology Index leads all hedge fund strategies with a 9.14% gain. Convertible Arbitrage is up 6.06%, and Fixed Income Arbitrage has gained 5.25%.

Equity Short Bias is the only hedge fund strategy with a loss in 2012. At the end of July, Equity Short Bias was down 7.33% for the year.

The Barclay Fund of Funds Index gained 0.67% in July, and is up 1.66% in 2012.

Click here to view five years of Barclay Hedge Fund Index data, or download 14 years of monthly data.

(press release)

www.barclayhedge.com

BarclayHedge was founded in 1985 and actively tracks more than 6,200 hedge funds, funds of hedge funds, and managed futures programs. Each month Barclay provides updated performance rankings for 38 Hedge Fund categories, 16 CTA categories, and 7 UCITS categories.

Bg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for